(Q43217665)

16 November 2017

0 references

Why hasn't the National Institute been 'NICE' to patients with colorectal cancer? National Institute of Clinical Excellence (English)

1 reference

16 November 2017

1 reference

2

1 reference

16 November 2017

M P Saunders

1

1 reference

PMC publication ID

2375412

16 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

British Journal of Cancer

16 November 2017

1 reference

16 November 2017

86

1 reference

16 November 2017

11

1 reference

16 November 2017

1667-1669

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

16 November 2017

start time

1 June 2002

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600369

0 references

cites work

Costs and consequences of different chemotherapy regimens in metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375412

Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375412

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375412

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375412

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375412

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375412

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

25 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12087447

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12087447

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12087447

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6600369

1 reference

16 November 2017

1 reference

PMC publication ID

2375412

16 November 2017

PubMed publication ID

12087447

1 reference

PMC publication ID

2375412